BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37245079)

  • 1. Surgical and Biochemical Outcomes in Nerve Monitored Reoperation Surgery for Recurrent Papillary Thyroid Carcinoma.
    Patel KR; Wang B; Abdelhamid Ahmed AH; Okose OC; Ma H; Behr IJ; Cheung AY; Saito Y; Kamani D; Silver Karcioglu A; Liddy W; Takami H; Cunnane M; Randolph GW
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1234-1240. PubMed ID: 37245079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural monitored revision thyroid cancer surgery: surgical safety and thyroglobulin response.
    Phelan E; Kamani D; Shin J; Randolph GW
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):47-52. PubMed ID: 23695590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
    Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revision neural monitored surgery for recurrent thyroid cancer: Safety and thyroglobulin response.
    Salari B; Ren Y; Kamani D; Randolph GW
    Laryngoscope; 2016 Apr; 126(4):1020-5. PubMed ID: 26608969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation.
    Yim JH; Kim WB; Kim EY; Kim WG; Kim TY; Ryu JS; Gong G; Hong SJ; Shong YK
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2049-56. PubMed ID: 21508143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
    Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
    Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma.
    Sun W; Di L; Chen L; Li D; Wu Y; Xiang J; Zhou S; Sun T
    BMC Surg; 2022 Nov; 22(1):374. PubMed ID: 36324095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.
    Al-Saif O; Farrar WB; Bloomston M; Porter K; Ringel MD; Kloos RT
    J Clin Endocrinol Metab; 2010 May; 95(5):2187-94. PubMed ID: 20332244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
    Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
    Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
    Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?
    Roh JL; Park JY; Rha KS; Park CI
    Head Neck; 2007 Oct; 29(10):901-6. PubMed ID: 17405173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia.
    Roh JL; Kim JM; Park CI
    Ann Surg Oncol; 2011 May; 18(5):1312-8. PubMed ID: 21140230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
    Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
    Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation.
    Park DJ; Lim JA; Kim TH; Choi HS; Ahn HY; Lee EK; Lee YJ; Kim KW; Park YJ; Yi KH; Cho BY
    Endocr J; 2012; 59(11):1021-30. PubMed ID: 22814366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
    Clayman GL; Agarwal G; Edeiken BS; Waguespack SG; Roberts DB; Sherman SI
    Thyroid; 2011 Dec; 21(12):1309-16. PubMed ID: 22136266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer.
    Hung ML; Wu JX; Li N; Livhits MJ; Yeh MW
    JAMA Surg; 2018 Dec; 153(12):1098-1104. PubMed ID: 30140908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate.
    Molteni G; Bonali M; Mattioli F; Ghirelli M; Fermi M; Ferri G; Andrea M; Presutti L
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):551-557. PubMed ID: 30535975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.